Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
KPX Holdings Co.,Ltd. (092230.KS)
Seoul, KR
Established in 2006 and headquartered in Seoul, South Korea, KPX Holdings Co.,Ltd. is a diversified enterprise operating across multiple sectors through its subsidiaries, specifically in chemical manufacturing, construction, and freight logistics. The company's chemical division is a primary supplier of polymer polyol and polyurethane (PU) systems, essential for various industries such as furniture, footwear, textiles, automotive, appliances, building construction, and container fabrication. This segment also specializes in producing active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemical products. In its logistics operations, KPX Holdings manages tank terminals and offers comprehensive services for handling and storing liquid freight. Furthermore, the company's construction and real estate ventures include developing and leasing properties, alongside the construction and rental of commercial and residential buildings.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.47% | -2.88% | -7.36% | +1.81% | +15.16% | +17.41% | +26.77% | +64.01% | +16.76% | +37.07% | +175.49% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Conglomerates: +6.1%-4.9% Q1'26: +5.2% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+1.6% Q1'26: +257.0% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+0.8% Q1'26: -0.8% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+3.7% Q1'26: +4.3% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+2.5% Q1'26: +3.0% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+7.5% Q1'26: +0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×3.13× ★ Q1'26: 3.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 3/5 | 4/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-15 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-14 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 5/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.01% | 64.9K | 0.15% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gyu-Mo Yang | Chairman and Chief Executive Officer | 857M | male |
| Jun-Yeong Yang | Vice-Chairperson and Chief Executive Officer | 551M | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 092230.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
